Overview

East African Pharmacovigilance Initiative (EAPI) is a partnership between the Pharmacy and Poisons Board and the University of Nairobi funded by European & Developing Countries Clinical Trials Partnership (EDCTP) grant number; EDCTP CSA Ethics 876 EAPI (CSA Ethics and Regulatory Capacities). The project also works with other organizations and stakeholders. The Pharmacy and Poisons Board (PPB) is the National Drug Regulatory authority in Kenya mandated to ensure that clinical trials involving the use of new investigational drugs and older drugs for new conditions or diseases or investigational devices in human subjects are in compliance with national regulations including procedures to protect the safety of all participants. The University of Nairobi is the first to train pharmacists in Kenya. University of Nairobi and the Pharmacy and Poisons Board are both jointly a Regional Center of Regulatory Excellence (RCORE) for Pharmacovigilance under the New Partnerships for African Development (NEPAD).